Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial

Toshihiko Doi, Yukinori Kurokawa, Akira Sawaki, Yoshito Komatsu, Masato Ozaka, Tsuyoshi Takahashi, Yoichi Naito, Shuichi Ohkubo, Toshirou Nishida

研究成果: Article査読

28 被引用数 (Scopus)

フィンガープリント

「Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences